TIMP-2 disrupts FGF-2-induced downstream signaling pathways

Dong Wan Seo(Dankook University), William G. Stetler‐Stevenson(Center for Cancer Research), Jeung‐Whan Han(Sungkyunkwan University), Tere Diaz(National Cancer Institute), Pyeung-Hyeun Kim(Kangwon National University), Hyun-Jae Yoon(Kangwon National University), Yong Kee Kim(Catholic Kwandong University), Beiyang Wei(National Cancer Institute), Young‐Rak Cho(Gyeonggi College of Science and Technology), Seok‐Hyun Eom(Kangwon National University), Soo Hyeon Kim(Chungnam National University)
Microvascular Research
July 30, 2008
10.1016/j.mvr.2008.07.003
Cited by 54

Related Papers

TIMP-2 Mediated Inhibition of Angiogenesis
|Cell|2003|510
Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)
|Gut|2020|332
Autoimmune Chronic Pancreatitis
|The American Journal of Gastroenterology|2004|288
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
|Brain Research|1992|282
Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
|PubMed|2000|279